191 related articles for article (PubMed ID: 19394311)
1. Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagata S; Kato J
Biochem Biophys Res Commun; 2009 Jun; 384(2):249-54. PubMed ID: 19394311
[TBL] [Abstract][Full Text] [Related]
2. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.
Ittner LM; Koller D; Muff R; Fischer JA; Born W
Biochemistry; 2005 Apr; 44(15):5749-54. PubMed ID: 15823033
[TBL] [Abstract][Full Text] [Related]
4. Role of the N-terminal domain of the calcitonin receptor-like receptor in ligand binding.
Chauhan M; Rajarathnam K; Yallampalli C
Biochemistry; 2005 Jan; 44(2):782-9. PubMed ID: 15641806
[TBL] [Abstract][Full Text] [Related]
5. Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET.
Héroux M; Breton B; Hogue M; Bouvier M
Biochemistry; 2007 Jun; 46(23):7022-33. PubMed ID: 17503773
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins.
Kuwasako K; Cao YN; Nagoshi Y; Tsuruda T; Kitamura K; Eto T
Mol Pharmacol; 2004 Jan; 65(1):207-13. PubMed ID: 14722252
[TBL] [Abstract][Full Text] [Related]
7. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
8. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
9. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
10. Studies on the effects of the N-terminal domain antibodies of calcitonin receptor-like receptor and receptor activity-modifying protein 1 on calcitonin gene-related peptide-induced vasorelaxation in rat uterine artery.
Chauhan M; Gangula PR; Wimalawansa SJ; Yallampalli C
Biol Reprod; 2004 Jun; 70(6):1658-63. PubMed ID: 14960487
[TBL] [Abstract][Full Text] [Related]
11. Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Kato J
Biochem Biophys Res Commun; 2010 Feb; 392(3):380-5. PubMed ID: 20074556
[TBL] [Abstract][Full Text] [Related]
12. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
McLatchie LM; Fraser NJ; Main MJ; Wise A; Brown J; Thompson N; Solari R; Lee MG; Foord SM
Nature; 1998 May; 393(6683):333-9. PubMed ID: 9620797
[TBL] [Abstract][Full Text] [Related]
13. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
14. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
[TBL] [Abstract][Full Text] [Related]
15. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
Hilairet S; Foord SM; Marshall FH; Bouvier M
J Biol Chem; 2001 Aug; 276(31):29575-81. PubMed ID: 11387328
[TBL] [Abstract][Full Text] [Related]
16. Functions of the extracellular histidine residues of receptor activity-modifying proteins vary within adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Kato J
Biochem Biophys Res Commun; 2008 Dec; 377(1):109-13. PubMed ID: 18835256
[TBL] [Abstract][Full Text] [Related]
17. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.
Bomberger JM; Parameswaran N; Hall CS; Aiyar N; Spielman WS
J Biol Chem; 2005 Mar; 280(10):9297-307. PubMed ID: 15613468
[TBL] [Abstract][Full Text] [Related]
18. N-Glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CRLR/RAMP3 adrenomedullin receptor.
Flahaut M; Pfister C; Rossier BC; Firsov D
Biochemistry; 2003 Sep; 42(34):10333-41. PubMed ID: 12939163
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
Born W; Muff R; Fischer JA
Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
[TBL] [Abstract][Full Text] [Related]
20. The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function.
Fitzsimmons TJ; Zhao X; Wank SA
J Biol Chem; 2003 Apr; 278(16):14313-20. PubMed ID: 12574158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]